Jaime is a freelance writer for The American Journal of Managed Care® (AJMC®), where she previously worked as an assistant editor.
She has a BA in print journalism from Penn State University. You can connect with Jaime on LinkedIn.
Paxlovid May Reduce Already Low Risk of COVID-19 Hospitalization, Death Among Vaccinated Patients
January 17th 2023Patients who received nirmatrelvir plus ritonavir (Paxlovid) had lower risk of both hospitalization within 14 days and death within 28 days compared with patients who did not receive the treatment.
Read More
Risk Prediction for Risk Mitigation in Prostate Cancer Explored in New Study
January 14th 2023The importance of identifying rare pathogenic mutations and genetic risk score among patients was explored in this new analysis, with goals that included reducing mortality and early disease detection.
Read More
Severity of SMA Muscle Impairment Prior to Treatment May Have Implications for Nusinersen Efficacy
December 26th 2022The findings, which the researchers say highlight the importance of early diagnosis and initiation of treatment, come amid efforts to determine efficacy trends among the several treatment options for the condition.
Read More
Repeated SMA Treatment With Nusinersen Does Not Result in Consistent Increase in Immune Responses
December 23rd 2022The findings, say the researchers, confirm that repeated intrathecal injections of the gene-targeting therapy are safe, adding to the limited data on the long-term effect and safety of the treatment approach in neurological diseases.
Read More
Managing GI Symptoms During OIT for Food Allergies
December 16th 2022Though a large proportion of patients receiving oral immunotherapy (OIT) for food allergy report gastrointestinal (GI) symptoms, a knowledge gap remains for the best approach to determine the underlying etiology and manage symptoms.
Read More
Modified Elimination Diet May Be Effective in Children With Eosinophilic Gastrointestinal Disorders
December 15th 2022Based on their retrospective findings, the researchers suggest the diet is a potentially effective option for these patients who may face challenges with other elimination diets.
Read More
Using Risk Factors to Guide CAR T Approach Before, After Infusion in B-ALL
December 8th 2022This paper follows the 10-year remission mark for the first child treated with CD19-targeted CAR (chimeric antigen receptor) T-cell therapy for B-cell acute lymphoblastic leukemia (B-ALL), adding promise to the notion that the technology can provide long-term durable remissions in patients who are highly refractory to chemotherapy.
Read More
Children With Psoriasis Should Be Screened for Mental Health Conditions, Say Researchers
December 6th 2022A review of available literature, although limited, has pointed to a link between pediatric psoriasis and anxiety and depression. Previous research has made a clear association between psoriasis and mood disorders in adults.
Read More
Researchers Find No Tumor Recurrence, Progression in Patients Receiving Biologic for Psoriasis
December 3rd 2022Data on the use of biologics for psoriasis among patients with a history of cancer have remained sparse. However, new findings provide the largest amount of real-world data on the use of the biologic secukinumab in these patients.
Read More
Multimorbidity May Increase Risk, Duration of Hospitalization for Patients With RA
December 2nd 2022With 60% to 75% of patients with rheumatoid arthritis (RA) developing other long-term conditions throughout their lifetime, the researchers underscored the importance of using multimorbidity in risk stratification of patients with RA based on their findings.
Read More
Systematic Review Highlights Inconsistent Evidence on Role of Diet in RA Risk
December 2nd 2022Generally, the studies suggested a decreased risk of rheumatoid arthritis (RA) associated with fish and vegetable consumption, as well as Mediterranean-style diets, although the researchers noted that these studies used varying methods and had varying results.
Read More
Predictors of Severe COVID-19 Infection, Mortality in Patients With MM, AL Identified
November 29th 2022Their findings, say the researchers, offer useful insights into the outcomes and risks of severe disease and mortality in patients who have multiple myeloma (MM) or amyloidosis (AL) with underlying monoclonal gammopathy who contract COVID-19.
Read More
Women With CKD Receiving Fertility Treatment Have Similar Birth Rates to Those Conceiving Naturally
November 28th 2022Researchers underscore a need for prospective data, noting that women with chronic kidney disease (CKD) tended to have higher rates of preterm delivery and lower birthweight.
Read More
MDD Treatment Alternatives Explore Potential of Cannabis, Psychedelics
November 28th 2022Stemming from recent data on a potential link between major depressive disorder (MDD) and inflammation, research is starting to turn toward alternatives that can treat the disease through anti-inflammatory effects, including ketamine, cannabinoids, and psychedelics.
Read More
Motor Function Continues to Improve in Second Year of Risdiplam Treatment for SMA
November 26th 2022Detailing findings from the secondary end points of the FIREFISH trial at 24 months, the researchers found that risdiplam treatment was associated with continued improvements in motor function and the achievement of development motor milestones.
Read More
Drops in Serum Phosphate Levels May Help Predict Severe CRS After CAR T
November 23rd 2022A new study has found that a drop in serum inorganic phosphate (iP) was an early predictor of severe cytokine release syndrome (CRS), suggesting that monitoring serum iP levels could help promote safer management of the most common toxicity associated with chimeric antigen receptor (CAR) T-cell therapy.
Read More
Certain CSF Biomarker May Foretell Nusinersen Response in Children With SMA
November 22nd 2022Using data from patients with spinal muscular atrophy (SMA) type 1 and 2, researchers observed that chitotriosidase 1 levels in cerebral spinal fluid (CSF) changed over time after treatment with nusinersen, suggesting that the change could be indicative of treatment response.
Read More
Data Suggest Next-Gen BTK Inhibitor Is More Favorable in Rare Form of NHBCL
November 8th 2022Zanubrutinib is the latest of 3 Bruton tyrosine kinase (BTK) inhibitors approved for rare B-cell malignancies, such as Waldenström macroglobulinemia, a non-Hodgkin B-cell lymphoma (NHBCL); as a next-generation BTK inhibitor, zanubrutinib is designed to have less off-target effects.
Read More
Researchers Provide Management Recommendations for CRS, Other Toxicities of CAR T
November 8th 2022While chimeric antigen receptor (CAR) T-cell therapy has offered a new option and improved outcomes for patients with advanced hematologic malignancies, the treatment approach has been associated with toxicities such as cytokine release syndrome (CRS), neurotoxicity, and hematotoxicity.
Read More
Could Combining Use of BTK Inhibition, CAR T-Cell Therapy Yield Better Outcomes in MCL?
November 6th 2022Recent research suggested the idea of combining chimeric antigen receptor (CAR) T-cell therapy and Bruton’s tyrosine kinase (BTK) inhibitors for certain patients with advanced mantle cell lymphoma (MCL).
Read More
Identifying SE in Initial Asthma Screening May Help Promote Precision Medicine
October 31st 2022The retrospective findings showed that searching for Staphylococcus aureus and its enterotoxins (SE) when initially screening patients for asthma can help with identifying a targeted treatment option by improving phenotyping and predicting comorbidities.
Read More